New cell therapy aims to mop up hidden colon cancer
NCT ID NCT05040568
Summary
This study tested a new combination treatment for people with colon cancer who had surgery and chemotherapy but still had tiny amounts of cancer left in their blood. The treatment used specially prepared immune cells (CB-NK cells) from donors, given along with the drug cetuximab. The main goal was to see if this combination could clear these hidden cancer cells from the blood and was safe for the 15 patients in this early-phase trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.